Stroke and phenylpropanolamine (continued).
D016022:Case-Control Studies; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D017277:Drug Approval; D004335:Drug and Narcotic Control; D005602:France; D006801:Humans; D014663:Nasal Decongestants / Q000008:administration & dosage / Q000009:adverse effects; D010665:Phenylpropanolamine / Q000008:administration & dosage / Q000009:adverse effects*; D013566:Sympathomimetics / Q000008:administration & dosage / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D014663:Nasal Decongestants; D013566:Sympathomimetics; D010665:Phenylpropanolamine